Video

Laura Topor Explains the Value of Real-Time Benefit Transactions

Real-time prescription benefit transactions are designed to give clinicians essential information on an individual patient’s benefits before writing a prescription, according to Laura Topor, president of Granada Health.

Real-time prescription benefit transactions are designed to give clinicians essential information on an individual patient’s benefits before writing a prescription, according to Laura Topor, president of Granada Health.

Transcript (slightly modified)

What are real-time prescription benefit transactions and what value do they provide?

Real-time benefit transactions are something that the industry is looking at as a way to provide the doctor at the point of prescribing with patient-specific information about their benefits. So, is the product covered? What’s the patient cost going to be? Are there coverage edits or a prior authorization required? Are there any pharmacy restrictions?

Because what’s often happening is they write the prescription, maybe it goes to a pharmacy that can’t fill that product, or the patient gets to the counter and realizes that they can’t afford the hundreds of dollars for that prescription, or it’s not on formulary, it needs a prior authorization.

So, it’s really trying to avoid those disruptors and dissatisfaction elements that delay therapy by providing that information to the prescriber before they send that prescription out the door.

Related Videos
Drs Lillian L. Siu and Matthew G. Vander Heiden
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Kimberly Westrich, MA, chief strategy officer, NPC
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Marla Black Morgan, MD, Phoebe Neurology Associates
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Bridgette Picou, LVN, ACLPN, The Well Project
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Richard Nowak, MD, MS, Yale School of Medicine
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo